AI assistant
SOLARA ACTIVE PHARMA SCIENCES LIMITED — Capital/Financing Update 2026
Mar 24, 2026
61842_rns_2026-03-24_64d2ecc2-c0ab-432d-a204-9e5e089a5153.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: [email protected] Website: www.solara.co.in
==> picture [181 x 70] intentionally omitted <==
Date: March 24, 2026
| Date: March 24, 2026 | |
|---|---|
| The BSE LimitedPhiroze Jeejeebhoy TowersDalalStreet,Mumbai – 400 001 | The National Stock Exchange of India LimitedExchange Plaza, C-1, Block G, Bandra-Kurla Complex,Bandra (E),Mumbai – 400 051 |
| Scrip Code: 541540, 890202 | Symbol: SOLARA, SOLARAPP1 |
Dear Sir / Madam,
==> picture [445 x 4] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 4] intentionally omitted <==
Sub: Intimation under Regulation 30 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Outcome of Rights Issue Committee Meeting dated March 24, 2026
==> picture [445 x 4] intentionally omitted <==
This is to inform you that the Meeting of the Rights Issue Committee of the Board of Directors of the Company held today i.e., Tuesday, March 24, 2026 has inter alia considered and approved the making of Second & Final call of ₹ 112.50/- per equity shares (₹ 3.00/- towards face value and ₹ 109.50/- towards securities premium) per Rights Share in respect of partly-paid Rights Shares, on Rights basis, pursuant to the Letter of Offer dated May 09, 2024. Rights Issue Committee has fixed Thursday, April 02, 2026, as the Record date for the purpose of determining the holders of partly paid-up Equity Shares to whom the call notice will be dispatched for payment of the call.
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 4] intentionally omitted <==
Details under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 has been enclosed herewith as Annexure I .
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 4] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 4] intentionally omitted <==
The Rights Issue Committee Meeting commenced at 9.30 A.M. and concluded at 9.55 A.M.
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 4] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
This is for your information and records.
==> picture [445 x 4] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 4] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
Yours faithfully, For Solara Active Pharma Sciences Limited
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 4] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
POOJA JAYA Digitally signed by POOJA JAYA KUMAR KUMAR Date: 2026.03.24 10:09:03 +05'30' Pooja Jaya Kumar Company Secretary and Compliance Officer ICSI Membership No. A57415 Encl.: as above
==> picture [445 x 4] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 4] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 4] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 4] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 4] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 4] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: 9th Floor, ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91-22-20870033
Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: [email protected] Website: www.solara.co.in
==> picture [181 x 70] intentionally omitted <==
Annexure – I
Details under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read along with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015, read with Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
==> picture [445 x 4] intentionally omitted <==
==> picture [459 x 314] intentionally omitted <==
----- Start of picture text -----
| Sr. | Particulars | Remarks | ||||
| No. | ||||||
| 1. | Forfeiture of shares | Not Applicable. | ||||
| 2. | Reissue | of | forfeited | shares | or | Not Applicable. |
| securities, or the issue of shares or | ||||||
| securities held in reserve for future | ||||||
| issue or the creation in any form or | ||||||
| manner of new shares or securities or | ||||||
| any other rights, privileges or benefits | ||||||
| to subscribe to | ||||||
| 3. | Proposal to issue any class of | Not Applicable | ||||
| securities; | ||||||
| 4. | Alterations of capital, including calls; | Second & Final call of ₹ 112.50/- per equity shares | ||||
| (₹ 3.00/- towards face value and ₹ 109.50/- towards | ||||||
| securities premium) per Rights Share in respect of | ||||||
| partly paid Rights Shares, on Rights basis, pursuant | ||||||
| to the Letter of Offer dated May 09, 2024. | ||||||
| 5. | Change | in | the | terms | regarding | Not Applicable |
| redemption/cancellation/retirement in | ||||||
| whole or in part of any securities issued | ||||||
| by the listed entity |
----- End of picture text -----
==> picture [445 x 4] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
For Solara Active Pharma Sciences Limited
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 4] intentionally omitted <==
==> picture [445 x 5] intentionally omitted <==
==> picture [445 x 40] intentionally omitted <==
----- Start of picture text -----
| POOJA | Digitally signed by |
| JAYA | POOJA JAYA KUMAR Date: 2026.03.24 |
| KUMAR | 10:09:23 +05'30' |
----- End of picture text -----
Pooja Jaya Kumar Company Secretary and Compliance Officer ICSI Membership No. A57415
Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: 9th Floor, ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91-22-20870033